Home Cart 0 Sign in  
X

[ CAS No. 17213-57-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
3d Animation Molecule Structure of 17213-57-9
Chemical Structure| 17213-57-9
Chemical Structure| 17213-57-9
Structure of 17213-57-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 17213-57-9 ]

Related Doc. of [ 17213-57-9 ]

Alternatived Products of [ 17213-57-9 ]

Product Details of [ 17213-57-9 ]

CAS No. :17213-57-9 MDL No. :MFCD00000676
Formula : C9H9ClO3 Boiling Point : -
Linear Structure Formula :- InChI Key :FTHPLWDYWAKYCY-UHFFFAOYSA-N
M.W : 200.62 Pubchem ID :87003
Synonyms :

Calculated chemistry of [ 17213-57-9 ]

Physicochemical Properties

Num. heavy atoms : 13
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.22
Num. rotatable bonds : 3
Num. H-bond acceptors : 3.0
Num. H-bond donors : 0.0
Molar Refractivity : 49.61
TPSA : 35.53 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.27 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.33
Log Po/w (XLOGP3) : 3.17
Log Po/w (WLOGP) : 2.08
Log Po/w (MLOGP) : 1.4
Log Po/w (SILICOS-IT) : 2.35
Consensus Log Po/w : 2.27

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.22
Solubility : 0.12 mg/ml ; 0.000596 mol/l
Class : Soluble
Log S (Ali) : -3.59
Solubility : 0.0519 mg/ml ; 0.000259 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.22
Solubility : 0.12 mg/ml ; 0.0006 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.67

Safety of [ 17213-57-9 ]

Signal Word:Danger Class:8
Precautionary Statements:P260-P264-P280-P301+P330+P331-P303+P361+P353-P304+P340-P305+P351+P338-P310-P321-P363-P405-P501 UN#:3261
Hazard Statements:H314 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 17213-57-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 17213-57-9 ]
  • Downstream synthetic route of [ 17213-57-9 ]

[ 17213-57-9 ] Synthesis Path-Upstream   1~6

  • 1
  • [ 17213-57-9 ]
  • [ 20469-65-2 ]
Reference: [1] European Journal of Organic Chemistry, 1998, # 2, p. 359 - 364
  • 2
  • [ 17213-57-9 ]
  • [ 877-88-3 ]
Reference: [1] Journal of Labelled Compounds and Radiopharmaceuticals, 2004, vol. 47, # 3, p. 167 - 174
  • 3
  • [ 17213-57-9 ]
  • [ 25245-27-6 ]
Reference: [1] Patent: CN107840792, 2018, A,
  • 4
  • [ 17213-57-9 ]
  • [ 65976-77-4 ]
Reference: [1] Acta Chemica Scandinavica (1947-1973), 1955, vol. 9, p. 246,249
  • 5
  • [ 17213-57-9 ]
  • [ 52189-63-6 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1980, p. 1658 - 1666
  • 6
  • [ 17213-57-9 ]
  • [ 75996-29-1 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1980, p. 1658 - 1666
Same Skeleton Products
Historical Records